# A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

> **NCT01342211** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 93 (actual)

## Conditions studied

- Hypercholesterolemia
- Dyslipidemia

## Interventions

- **BIOLOGICAL:** Placebo
- **DRUG:** Statin
- **BIOLOGICAL:** PF-04950615 (RN316)
- **DRUG:** Statin
- **BIOLOGICAL:** PF-04950615 (RN316)
- **DRUG:** Statin
- **BIOLOGICAL:** PF-04950615 (RN316)
- **DRUG:** Satin
- **BIOLOGICAL:** PF-04950615 (RN316)
- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT01342211
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342211, "A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01342211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*